PDL BioPharma, Inc. Consolidated Net Income/Loss

Consolidated Net Income/Loss of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Consolidated Net Income/Loss growth rates and interactive chart.


Highlights and Quick Summary

  • Consolidated Net Income/Loss for the quarter ending June 29, 2020 was $-50.3 Million (a 57.22% increase compared to previous quarter)
  • Year-over-year quarterly Consolidated Net Income/Loss increased by 180.13%
  • Annual Consolidated Net Income/Loss for 2019 was $-70.7 Million (a 2.66% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2018 was $-68.9 Million (a -162.2% decrease from previous year)
  • Annual Consolidated Net Income/Loss for 2017 was $111 Million (a 73.9% increase from previous year)
  • Twelve month Consolidated Net Income/Loss ending June 29, 2020 was $-155 Million (a 41.91% increase compared to previous quarter)
  • Twelve month trailing Consolidated Net Income/Loss decreased by -37391.59% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-155 Million $-109 Million $-70.7 Million $416 Thousand
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Consolidated Net Income/Loss of PDL BioPharma, Inc.

Most recent Consolidated Net Income/Lossof PDLI including historical data for past 10 years.

Interactive Chart of Consolidated Net Income/Loss of PDL BioPharma, Inc.

PDL BioPharma, Inc. Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-50.33 $-32.01
2019 $-54.83 $-17.97 $-4.51 $6.62 $-70.69
2018 $16.28 $25.56 $-112.3 $1.6 $-68.86
2017 $22.34 $20.73 $60.44 $7.19 $110.7
2016 $-10.28 $13.9 $4.15 $55.89 $63.66
2015 $100.57 $69.46 $78.26 $84.5 $332.8
2014 $55.07 $102.24 $92.06 $72.88 $322.24
2013 $61.09 $56.23 $93.74 $53.47 $264.53
2012 $49.41 $48.58 $73.5 $40.18 $211.67
2011 $38.94 $45.92 $69.99 $44.55 $199.39
2010 $-24.46 $40.19 $50.14 $91.87

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.